Trial intelligence / Profile preview

Bupivacaine plus fentanyl for spinal anesthesia during TUL for proximal ureteral stones

IRCT20210206050260N1Phase 3Completed

Sponsor
Urology Research Center
Start
Apr 2021
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of bupivacaine and fentanyl in ureterolithiasis (2 arms), sponsored by Urology Research Center. Primary endpoints: Level of sensory block, Level of movement block and 1 more. Started Apr 2021; status: completed.

02

Drugs

bupivacainefentanyl
03

Conditions

ureterolithiasis

Beyond the preview

Go deeper on IRCT20210206050260N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210206050260N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call